XML 106 R33.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Stock Option Activity

A summary of the Company’s stock option activity under the 2021 Plan and 2018 Plan is as follows (in thousands, except share and per share data and years):

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

Weighted-

 

 

average remaining

 

 

Aggregate

 

 

 

 

 

 

average

 

 

contractual

 

 

intrinsic

 

 

 

Shares

 

 

exercise price

 

 

term (years)

 

 

value

 

Outstanding at December 31, 2020

 

 

6,541,422

 

 

$

0.98

 

 

 

9.23

 

 

$

15,571

 

Granted

 

 

8,320,187

 

 

 

5.93

 

 

 

 

 

 

 

Exercised

 

 

(736,200

)

 

 

1.88

 

 

 

 

 

 

 

Canceled

 

 

(307,197

)

 

 

2.97

 

 

 

 

 

 

 

Outstanding at December 31, 2021

 

 

13,818,212

 

 

$

3.87

 

 

 

8.82

 

 

$

163,264

 

Options exercisable at December 31, 2021

 

 

3,161,831

 

 

$

1.63

 

 

 

8.29

 

 

$

44,119

 

Summary of Restricted Stock Activity

The summary of the Company’s restricted stock activity during the year ended December 31, 2021 is as follows:

 

 

 

Number of

 

 

Weighted-

 

 

 

restricted

 

 

average

 

 

 

stock shares

 

 

grant date

 

 

 

outstanding

 

 

fair Value

 

Nonvested at December 31, 2020

 

 

557,731

 

 

$

0.001

 

Vested

 

 

(344,790

)

 

 

0.001

 

Nonvested at December 31, 2021

 

 

212,941

 

 

$

0.001

 

 

Schedule of Stock-based Compensation Expense

The allocation of stock-based compensation for all stock awards was as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Research and development

 

$

4,957

 

 

$

348

 

General and administrative

 

 

3,374

 

 

 

449

 

Total

 

$

8,331

 

 

$

797

 

Summary of Common Stock Reserved for Future Issuance

Common stock reserved for future issuance consisted of the following as of December 31, 2021 and 2020:

 

 

 

December 31,

 

 

December 31,

 

 

 

2021

 

 

2020

 

Conversion of preferred stock outstanding

 

 

 

 

 

57,987,216

 

Conversion of preferred stock in future issuance (B-2)

 

 

 

 

 

10,979,319

 

Stock options issued and outstanding

 

 

13,818,212

 

 

 

6,541,422

 

Awards available for future grant

 

 

14,699,430

 

 

 

2,314,746

 

Shares available for purchase under the ESPP

 

 

1,168,013

 

 

 

 

Total

 

 

29,685,655

 

 

 

77,822,703

 

Stock Options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Assumptions used to Determine Fair Value of Stock Option Grants and Stock to be Purchased under ESPP

The assumptions used in the Black-Scholes option pricing model to determine the fair value of the employee and nonemployee stock option grants were as follows:

 

 

 

Year Ended December 31,

 

 

2021

 

2020

Risk-free interest rate

 

0.59%-1.34%

 

0.37%-1.22%

Expected volatility

 

81.93%-85.35%

 

74.72%-77.81%

Expected term (in years)

 

6.08

 

6.02-6.25

Expected dividend yield

 

--%

 

--%

ESPP  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Assumptions used to Determine Fair Value of Stock Option Grants and Stock to be Purchased under ESPP

The assumptions used in the Black-Scholes option pricing model to determine the fair value of the stock to be purchased under the ESPP were as follows:

 

 

Year Ended December 31,

 

 

2021

 

2020(1)

Risk-free interest rate

 

0.05%-0.64%

 

--%

Expected volatility

 

70.99%-91.69%

 

--%

Expected term (in years)

 

0.39-2.00

 

--

Expected dividend yield

 

--%

 

--%

 

The ESPP was not in effect until 2021